Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1983;5:701-705

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Falardeau, P.
Right arrow Articles by Martineau, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Falardeau, P.
Right arrow Articles by Martineau, A.

Hypertension, Vol 5, 701-705, Copyright © 1983 by American Heart Association


ARTICLES

In vivo production of prostaglandin I2 in Dahl salt-sensitive and salt- resistant rats

P Falardeau and A Martineau

Prostaglandin I2 (PGI2, prostacyclin), a potent vasodilator synthesized by the blood vessels, has been postulated to play a role in hypertension. The purpose of our study was to test this hypothesis by monitoring the in vivo production of PGI2 in Dahl salt-sensitive (S) and salt-resistant (R) rats under normal and high sodium intake. The 24- hour urinary excretion of two endogenous metabolites of PGI2, 2-,3- dinor-6-oxo-PGF1 alpha, an 2,3-dinor-13,14-dihydro-6,15-dioxo-PGF1 alpha was measured by combined gas chromatography-mass spectrometry (GC- MS) and used as an index of the total production of PGI2 by the animals. The pattern of urinary excretion of these two metabolites in the R and the S rats during the control period indicated that, under normal conditions, early in life the basal production of PGI2 was the same in both groups of rats. Following the chronic administration of a high sodium diet (8.1% sodium chloride, starting at 36 days of age), a significant and sustained increase in the urinary excretion of 2,3- dinor-6-oxo-PGF1 alpha was documented in the R rats (from 37 +/- 7 ng/24 hrs at age 35 days to 63 +/- 7, 52 +/- 4, and 56 +/- 10 ng/24 hrs at 50, 60, and 80 days, respectively), whereas the urinary levels of this metabolite decreased slightly in the S rats (from 41 +/- 7 ng/24 hrs at age 35 days to 25 +/- 5, 30 +/- 6, and 28 +/- 9 ng/24 hrs at 50, 60, and 80 days, respectively). During the same period, the R rats remained normotensive (103 +/- 5 mm Hg, systolic pressure) while the arterial pressure of the S rats increased gradually (to 142 +/- 8 and 180 +/- 19 mm Hg at ages 60 and 80 days, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Yang, I. Singh, H. Pham, D. Sun, A. Smart, J. B. Schnermann, and J. P. Briggs
Regulation of cyclooxygenase expression in the kidney by dietary salt intake
Am J Physiol Renal Physiol, March 1, 1998; 274(3): F481 - F489.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
T. Kato, S. Yoneda, M. Koketsu, and T. Fujinami
Effects of Prostacyclin Infusion on Blood Pressure and Plasma Renin Activity in Patients with Essential Hypertension
Angiology, February 1, 1992; 43(2): 110 - 120.
[Abstract] [PDF]